In patients suffering from colon adenocarcinoma and hepatocarcinoma, we have found an increase on GLUT12 and GLUT1 protein expression in tumors compared to adjacent non-tumor tissue, while the tumor suppressor p53 showed a diminishing trend (Fig. 5A and B). Here, SLC2A1 is linked to neoplasm.